Tontanai Numbenjapon

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

Jesús F. San Miguel, Vânia Hungria, Sung‐Soo Yoon et al. · The Lancet Oncology · 2014 · 781 citations

Hematological Malignancy, Double-blind Phase 3, Medicine +9

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy

Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares et al. · Blood · 2005 · 93 citations · Full text

A prospective evaluation of normal mean platelet volume in discriminating hyperdestructive thrombocytopenia from hypoproductive thrombocytopenia

Tontanai Numbenjapon, N. MAHAPO, Rachanid Pornvipavee et al. · International Journal of Laboratory Hematology · 2007 · 63 citations

Immunohematology, Platelet Pathobiology, Mean Platelet Volume +24

Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft Models

Tontanai Numbenjapon, Jianyi Wang, David Colcher et al. · Clinical Cancer Research · 2009 · 52 citations · Full text

Non‐Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand

Tanin Intragumtornchai, Udomsak Bunworasate, Kitsada Wudhikarn et al. · Hematological Oncology · 2017 · 46 citations